Oric Pharmaceuticals (ORIC) EPS (Basic) (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted EPS (Basic) of -$1.33 for Q1 2026, down 239.67% on a QoQ basis from -$0.39 in Q4 2025, and down 111.75% year-over-year from $11.32 in Q1 2025.
Oric Pharmaceuticals (ORIC) EPS (Basic) (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$1.33 for Q1 2026.
- Quarterly EPS (Basic) fell 111.75% year-over-year to -$1.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.67 (up 35.76% YoY) and the FY2025 annual result came in at -$4.05, up 10.54% from the prior year.
- EPS (Basic) was -$1.33 for Q1 2026 at Oric Pharmaceuticals, down from -$0.39 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.39 in Q4 2025 and bottomed at -$3.18 in Q4 2023.
- A 5-year average of -$1.19 and a median of -$0.84 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) slumped 478.54% — and 2025, when it soared 87.15%.
- Oric Pharmaceuticals' EPS (Basic) stood at -$0.55 in 2022, then plunged by 478.54% to -$3.18 in 2023, then grew by 4.27% to -$3.05 in 2024, then surged by 87.15% to -$0.39 in 2025, then tumbled by 239.67% to -$1.33 in 2026.
- Business Quant data shows ORIC's EPS (Basic) at -$1.33 in Q1 2026, -$0.39 in Q4 2025, and -$1.18 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -1.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 |
| Dec 31, 2025 | -0.39 |
| Sep 30, 2025 | -1.18 |
| Jun 30, 2025 | -1.22 |
| Mar 31, 2025 | -0.63 |
| Dec 31, 2024 | -3.05 |
| Sep 30, 2024 | -1.26 |
| Jun 30, 2024 | -0.84 |
| Mar 31, 2024 | -1.76 |
| Dec 31, 2023 | -3.18 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -1.20 |
| Mar 31, 2023 | -0.84 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.72 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.75 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -1.70 |
| Jun 30, 2021 | -1.56 |